Trending...
- Gospel Sensation "Bible, Faith, Rembrandt aka BFR, They're Taking the World by Storm
- SQHWYD Launches Cognitive Finance Platform with Intelligent Trading Technology and Unified DeFi Access for Brazilian Market
- How a Personal Injury Lawyer Can Assist in Your WorkCover Claim
Communities deserve answers on the potential role psychotropic drugs and treatments may have in senseless acts of violence—an issue too long suppressed by vested interests.
LOS ANGELES - AussieJournal -- By CCHR International
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Aussie Journal
Regulators have long issued warnings:
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Aussie Journal
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Aussie Journal
- 16653 Broadwater Ave in Winter Garden's Twinwaters Community Goes Under Contract in Just 22 Days — Far Outpacing the Local Average
- Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
- Walker's Restaurant Group Expands to Marriottsville with Barrington Tap & Table
- U.S. Creative Chosen as Dual Judge for China's Most Prestigious Animation & Comics Awards
- American Garden Rose Selections™ Announces 2026 Winners
Regulators have long issued warnings:
- The Food and Drug Administration (FDA) has logged at least 1,530 reports of homicide or homicidal ideation associated with psychiatric drugs.
- FDA advisories (2004, 2005) highlighted risks of agitation, hostility, and suicidal behavior on antidepressants. It also warns of homicidal ideation with one SSRI.[2]
- Health Canada warned of SSRIs' "potential for harm, including suicidal thoughts and the onset or worsening of agitation-type adverse events."[3]
- Australian regulators linked stimulants such as dextroamphetamine and atomoxetine to homicidal thoughts.[4]
- The European Medicines Agency reported increased aggression in children and adolescents taking SSRIs.[5]
- FDA Black Box Warnings already acknowledge suicidal thoughts on drugs such as the ADHD drug Strattera (atomoxetine hydrochloride) and antidepressants.
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
- U.S. and European incidents in 2025 revealed perpetrators with histories of psychiatric drug treatment or active prescriptions.
- Investigators in Sweden concluded that one mass killer acted under the influence of amphetamine and sedative drugs.
- Reports from Tennessee, Florida, New York, and Germany similarly documented psychiatric drugs in connection with acts of mass violence.
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Aussie Journal
- Asia Pacific industrial and logistics market shows signs of rebalancing
- Green Office Partner Secures the #1 Spot on Chicago Sun-Times' Best Workplace List Two Years Running
- AdvisorVault Releases New Explainer Video on their 17a-4 Managed 365 Service
- Freelance Clinical Invites Vendors to Claim Platform Early Access
- Applications Now Open for Raymond James Gasparilla Festival of the Arts Emerging Artists Program
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
- Families who lost loved ones deserve clear answers.
- Communities living in fear need prevention strategies grounded in science, not industry spin.
- Policymakers must have accurate data to legislate effectively.
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Source: Citizens Commission on Human Rights International
0 Comments
Latest on Aussie Journal
- Announcing the "Utsunomiya Gyoza Festival 2025" to be held November 1 and 2 in Utsunomiya City, Tochigi Pref, Japan
- Melbourne Aircon Specialist Launches Spring Sale with Rebates Up to $7,000 Under VEU Program
- Buyers Advocate Perth Marks Two Years of Redefining the Property Buying Experience
- Lineus Medical Obtains CE Mark for Flagship Product SafeBreak Vascular
- Sine Nomine Associates: OpenAFS Google Summer of Code projects have been completed
- HuskyTail Digital Marketing Rings in Fall with Free SEO Audits for Local Businesses
- David White DDS Advances Implant Dentistry with New Technology Acquisition
- Final Countdown: The OpenSSL Conference 2025 Begins in One Week
- New Frontier Aerospace Appoints Industry Veteran Rich Pournelle as Director of Business Development
- AI's Urgent Energy Requirements Won't Be Solved By Trillions Of Dollars. Phinge's Patented App-Less Netverse Platform & Hardware Will Reduce This Need
- DigiTotal Pty Ltd launches AI SEO, ads, CRO, and web/app dev for Melbourne businesses
- $750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
- €6.4 Million in Contracts Across Multiple Countries; Smart City Developer; U.S. Expansion, and Announces Strategic Drone Tech Partnership; $AFFU
- CRYPTOCURRENCY: Lucrumia Exchange Platform Addresses Italian Traders' Growing Demand for Secure Digital Asset Trading
- NIUFO Launches Secure Trading Platform for Italian Market Seeking Stability After 20% User Decline
- OrderDomains.com Empowers Businesses with Premium Domains and Flexible Financing
- Cryptocurrency Trading: AHRFD Enters German Market with Institutional-Grade Infrastructure
- TSWHZC Launches Automated Copy Trading Platform for Brazil's 28 Million Crypto Users
- Keyanb Crypto Exchange Unveils Comprehensive Platform Architecture for Chilean Traders Seeking Lower Fees and Enhanced Security
- Phoenix Advocacy Network Launches to Amplify Survivor Voices and Advance Disability Rights